Thomas Gad, See remarks at Y-mAbs Therapeutics, Inc. (YMAB), sold 100,000 shares at $17.06 ($1.7M) on 2021-11-23, disclosed to the SEC on 2021-11-26.
Open-market sale of $1.7M YMAB by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.06 | 50,000 | $853K | 50.0% |
| 2 | $17.06 | 50,000 | $853K | 50.0% |
| Total | $17.06 avg | 100,000 | $1.7M | 100% |
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |